In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: Sibutramine is a reuptake inhibitor

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 2, 1997, Pages 581-591

  Gundlah, C ^a   Martin, K F ^a,b   Heal, D J ^a,b   Auerbach, S B ^a  

^a RUTGERS UNIVERSITY   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINO 1 [1 (4 CHLOROPHENYL)CYCLOBUTYL] 3 METHYLBUTANE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; DRUG VEHICLE; FENFLURAMINE; FLUOXETINE; IMIPRAMINE; MONOAMINE; NISOXETINE; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE;

AMINE TRANSPORT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE UPTAKE; CONTROLLED STUDY; DRUG SELECTIVITY; HYPOTHALAMUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; MONOAMINE RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SUBCUTANEOUS DRUG ADMINISTRATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; CYCLOBUTANES; FENFLURAMINE; FLUOXETINE; MALE; MICRODIALYSIS; PAROXETINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 0030831763     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. ADELL A. AND ARTIGAS F.: Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. Naunyn-Schmiedeberg's Arch. Pharm. 343: 237-244, 1991.
2. AGHAJANIAN, G. K.: Chemical feedback regulation of serotonin-containing neurons in brain. Annals N.Y. Acad. Sci. 193: 86-94, 1972.
3. AUERBACH, S. B., LUNDBERG, J. F. AND HJORTH S.: Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration. Neuropharmacology 34: 89-96, 1995.
4. AUERBACH, S. B., MINZENBERG, M. J. AND WILKINSON, L. O.: Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electrochemical detection: dialysate serotonin reflects neuronal release. Brain Res. 499: 281-290, 1989.
5. BEL, N. AND ARTIGAS, F.: Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur. J. Pharmacol. 229: 101-103, 1992. [published erratum appears in Eur. J. Pharmacol. 232: 326, 1993].
6. BERGER, U. V., Gu, X. F. AND AZMITIA, E. C.: The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine. Eur. J. Pharmacol. 215: 153-160, 1992.
7. BLIER P., DE MONTIGNY C. AND CHAPUT Y.: Modifications of the serotonin system by antidepressant treatments: Implications for the therapeutic response in major depression. J. Clin. Psychopharm. 17: 24s-35s, 1987.
8. BONNANO, G., FASSIO, A., SEVERI, P., RUELLE, A. AND RAITERI, M.: Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism. J. Neurochem. 63: 1163-1166, 1994.
9. BUCKETT, W. R., THOMAS, P. C. AND LUSCOMBE, G. P.: The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation. Prog. Neuro-psychopharmacol. Biol. Psychiatry 12: 575-584, 1988.
10. CACCIA, S., ANELLI, M., CODEGONI, A. M., FRACASSO, C. AND GARRATTINI, S.: The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain. Br. J. Pharmacol. 110: 355-359, 1993.
11. CARBONI, E. AND DICHIARA, G.: Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience 32: 637-645, 1989.
12. 3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments. Neuropharmacology 35: 63-70, 1996.
13. 3H]5-HT uptake: Effect of administration of various antidepressant treatments. Neuropharmacology 32: 737-743, 1993.
14. FANTINO, M. AND SOUQUET, A. M.: Effects of metabolites 1 and 2 of sibutramine on the short-term control of food intake in the rat. Int. J. Obesity 19: 145, 1995.
15. FATTACCINI, C. M., GOZLAN, H. AND HAMON, M.: Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain. Neuropharmacology 30: 15-23, 1991.
16. FRANCIS, J., CRITCHLEY, D., DOURISH, C. T. AND COOPER, S. J.: Comparison between the effects of 5-HT and dl-fenfluramine on food intake and gastric emptying in the rat. Pharmacol. Biochem. and Behav. 50: 581-585, 1995.
17. FULLER, R. W.: Microdialysis studies with 5-HT reuptake inhibitors. Trends Pharmacol. Sci. 14: 397-398, 1993.
18. FULLER, R. W., SNODDY, H. D. AND ROBERTSON, D. W.: Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release. Pharmacol. Biochem. Behav. 30: 715-721, 1988.
19. FULLER, R. W. AND WONG, D. T.: Serotonin uptake and serotonin uptake inhibition. Ann. N.Y. Acad. Sci. 600: 68-72, 1990.
20. GARATTINI, S., MENNINI, T., BENDOTTI, C., INVERNIZZI, R. AND SAMANIN, R.: Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system. Appetite 7: 15-38, 1986.
21. GARATTINI, S., MENNINNI, T. AND SAMANIN, R.: Reduction of food intake by manipulation of central serotonin. Br. J. Psychiatry 155: 41-51, 1989.
22. 3H] serotonin. Naunyn-Schmiedeberg Arch. Pharmacol. 345: 1-6, 1992.
23. 3H]5-hydroxytryptamine induced by d-fenfluramine in rat hippocampal synaptosomes. Eur. J. Pharmacol. 238: 9-17, 1993.
24. GOODWIN, G. M., DE SOUZA, R. J., GREEN, A. R. AND HEAL, D. J.: The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy2-(di-n-propylamino)tetralin (8-OH-DPAT). Psychopharmacology. 91: 506-511, 1987.
25. GUDELSKY, G. A. AND NASH, J. F.: Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions. J. Neurochem. 66: 243-249, 1996.
26. GUNDLAH, C., MARTIN, K. F., HEAL, D. J., SCHJOTT, J. AND AUERBACH, S. B.: In vivo criteria to differentiate monoamine uptake inhibitors (maris) from serotonin releasing drugs: sibutramine is a mari. Soc. Neurosci. Abstract 244: 13, 1996.
27. 1A autoreceptors in the action of selective serotonin reuptake inhibitors. Eur. J. Pharmacol. 260: 251-255, 1994.
28. 1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. J. Pharmacol. Exp. Ther. 265: 707-712, 1993.
29. HYTTEL, J.: Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int. Clin. Psychopharm. 9: (Suppl. 1) 19-26, 1994.
30. JACKSON, H. C., NEEDHAM, A. M., HUTCHINS, L. J., MAZURKIEWICZ, S. E. AND HEAL, D. J.: Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat. Br. J. Pharmacol. 121:1758-1762, 1997.
31. KALÉN, P., STRECKER, R. E., ROSENGREN, E. AND BJORKLUND, A.: Endogenous release of neuronal serotonin and 5-hydroxyindoleacetic acid in the caudateputamen of the rat as revealed by intracerebral dialysis coupled to high-performance liquid chromatography with fluorimetric detection. J. Neurochem. 51: 1422-1435, 1988.
32. KREISS, D. S., WIELAND, S. AND LUCKI, I.: The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release. Neuroscience 52: 295-301, 1993.
33. KUHN, D. M., WOLF, W. A. AND YOUDIM, M. B. H.: 5-Hydroxytryptamine-release in vivo from a cytoplasmic pool: studies on the 5-HT behavioral syndrome in reserpinized rats. Br. J. Pharmacol. 84: 121-129, 1985.
34. LEVI, G. AND RAITERI, M.: Carrier-mediated release of neurotransmitters. Trends Neurosci. 16: 415-419, 1993.
35. LUSCOMBE, G. P., HOPCROFT, R. H., THOMAS, P. C. AND BUCKETT, W. R.: The contribution of metabolites to the rapid and potent down-regulation of rat cortical β-adrenoceptors by the putative antidepressant sibutramine hydrochloride. Neuropharmacology. 28: 129-134, 1989.
36. MENNINI, T., BORRONI, E., SAMANIN, R. AND GARATTINI, S.: Evidence of the existence of two different intraneuronal pools from which pharmacological agents can release serotonin. Neurochem. Int. 3: 289-294, 1981.
37. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney, Australia, 1982.
38. PERRY, K. W. AND FULLER, R. W.: Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci. 50: 1683-1690, 1992.
39. PRESKORN, S.: Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline. Int. Clin. Psychopharm. 9: (Suppl. 3:) 13-19, 1994.
40. RAITERI, M., BONANNO, G. AND VALLEBUONA, F.: In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia. J. Pharmacol. Exp. Ther. 273: 643-649, 1995.
41. RUDNICK, G. AND WALL, S. C.: p-Chloroamphetamine induces serotonin release through serotonin transporters. Biochemistry 31: 6710-6718, 1992.
42. RUTTER, J. J. AND AUERBACH, S. B.: Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J. Pharmacol. Exp. Ther. 265: 1319-1324, 1993.
43. RUTTER, J. J., GUNDLAH, C. AND AUERBACH, S. B.: Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation. Synapse 20: 225-233, 1995.
44. SABOL, K. E., RICHARDS, J. B. AND SEIDEN, L. S.: Fluoxetine attenuates the d, l-fenfluramine-induced increase in extracellular serotonin as measured by in vivo dialysis. Brain Res. 585: 421-424, 1992a.
45. SABOL, K. E., RICHARDS, J. B. AND SEIDEN, L. S.: Fenfluramine-induced increases in extracellular hippocampal serotonin are progressively attenuated in vivo during a four-day fenfluramine regimen in rats. Brain Res. 571: 64-72, 1992b.
46. SATO, Y., SHIBANOKI, S., SUGAHARA, M. AND ISHIKAWA, K.: Measurement and pharmacokinetic analysis of imipramine and its metabolite by brain microdialysis. Br. J. Pharmacol. 112: 625-629, 1994.
47. 1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br. J. Pharmacol. 96: 283-290, 1989.
48. SHARP, T., ZETTERSTROM, T., CHRISTMANSON, L. AND UNGERSTEDT, U.: p-Chloroamphetamine releases both serotonin and dopamine into rat brain dialysates in vivo. Neurosci. Lett. 72: 320-324, 1986.
49. SHEARD, M. H., ZOLOVICK, A. AND AGHAJANIAN, G. K.: Raphe neurons: Effect of tricyclic antidepressant drugs. Brain Res. 43: 690-694, 1972.
50. 3H]Nisoxetine: A new radioligand for norepinephrine uptake sites in brain. Eur. J. Pharmacol. 191: 239-243, 1990.
51. WONG, D. T., BYMASTER, F. P., MAYLE, D. A., REID, L. R., KRUSHINSKI, J. H. AND ROBERTSON, D. W.: LY248686, a new inhibitor of serotonin and norepinephrine uptake. Neuropharmacology 8: 23-33, 1993.